Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroleptic malignant syndrome.

A M Parikh1, E G Camara

  • 1Cleveland Clinic Foundation, Ohio.

American Family Physician
|February 1, 1988
PubMed
Summary
This summary is machine-generated.

Neuroleptic malignant syndrome, a rare but serious reaction to psychotropic drugs, presents with fever, muscle stiffness, and altered consciousness. Treatment involves supportive care and medications like dantrolene or bromocriptine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cumulative summation (CUSUM) charts in the monitoring of hypospadias outcomes: a tool for quality improvement initiative.

Journal of pediatric urology·2013
Same author

Precautions and complications in the use of the urolume wallstent.

European urology·1995
Same author

Premenstrual syndrome: a guide for the clinician.

Hawaii medical journal·1994
Same author

Renal adenocarcinoma in young adults.

Urologia internationalis·1994
Same author

New intra-ureteral stent for use during reconstructive surgery.

European urology·1994
Same author

A new technique for removal of the urolume prostate stent.

British journal of urology·1993
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Area of Science:

  • Neuroscience
  • Pharmacology
  • Critical Care Medicine

Background:

  • Neuroleptic malignant syndrome (NMS) is a severe adverse drug reaction.
  • It is associated with the use of neuroleptic and other psychotropic medications.
  • Key features include hyperthermia, muscular rigidity, and autonomic instability.

Purpose of the Study:

  • To summarize the key characteristics of neuroleptic malignant syndrome.
  • To outline diagnostic considerations, including normal cerebrospinal fluid findings.
  • To describe current treatment strategies for NMS.

Main Methods:

  • Review of clinical presentation and diagnostic criteria for NMS.
  • Discussion of laboratory findings, emphasizing normal cerebrospinal fluid.

Related Experiment Videos

  • Overview of therapeutic interventions for managing NMS.

    • Main Results:

    • NMS is clinically defined by hyperthermia, severe muscle rigidity, altered mental status, and autonomic dysfunction.
    • Cerebrospinal fluid analysis typically reveals normal results, aiding in differential diagnosis.
    • Treatment success is associated with prompt supportive care and specific pharmacologic agents.

    Conclusions:

    • Neuroleptic malignant syndrome requires prompt recognition and management.
    • Intensive supportive care is fundamental to patient recovery.
    • Pharmacologic options such as dantrolene and bromocriptine are crucial in treating NMS.